Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank75
5Y CAGR+18.5%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
+18.5%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202540.49%
20241.17%
202313.68%
2022-3.54%
202181.36%
202017.33%
201928.76%
20181876.29%
20170.00%